drugset / Trial / NCT01106846

Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery

NCT01106846 ↗

Terminated 22 enrolled Northwestern University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Hypothesis: The intraoperative administration of ketamine will result in a 30% reduction in opiate requirement following endometrial ablation surgery and the intraoperative administration of ketamine will result in a decreased time to meet discharge criteria in the PACU following endometrial ablation surgery. The research question is "Does intraoperative administration of ketamine result in decreased postoperative opiate requirement and time to discharge from the postanesthesia recovery unit (PACU) following hysteroscopic endometrial ablation".

Timeline

Start
2010-03
Primary completion
2013-03
Completion
2013-03

Outcome

Outcome not reported

Stopped: “Resources not available to complete.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1 % Intravenous

Indications

No indication recorded.